21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Combined use of factor VII polypeptides and factor IX polypeptides
#21302Methods useful in the treatment of bone resorption diseases
#21303Mucosal repair by TFF dimer peptides
#21304Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
#21305Nitrosated and nitrosylated heme proteins
#21306Methods of treating or preventing a disease, disorder or condition associated with a viral infection
#21307Anti-obesity agent
#21308Compositions and methods for prostate and kidney health and disorders, an herbal preparation
#21309Synergistic Effects of Nuclear Transcription Factor NF-kB Inhibitors and Anti-Neoplastic Agents
#21310Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes
#21311Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
#21312Methods and compositions involving aldose reductase
#21313Supplemental dietary composition for promoting weight loss
#21314Method and kit to cure chronic cough
#21315Method for treating an inflammation or lesion caused by a virus
#21316Cartilage repair mixture containing allograft chondrocytes
#21317Zinc-containing sustained-release composition, its preparation, and method for producing the same
#21318Water-soluble isoflavone composition, process for producing the same, and use thereof
#21319Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same
#21320Methods of diagnosing sepsis by measuring HMG1
#21321Administration of anti-cytokine f(ab')2 antibody fragments
#21322Dosages for treatment with anti-EGFR antibodies
#21323Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
#21324Compositions and methods for systemic inhibition of cartilage degradation
#21325Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
#21326Method for reducing obstructive hydrocephalus
#21327Process for treating spirulina
#21328Means and methods for the recruitment and identification of stem cells
#21329Method of attenuating neurogenic bruise formation
#21330Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#21331Article with skin protecting and moisturizing compound
#21332Chemical composition and method for cold and sinus relief
#21333Pharmaceutical compositions having appetite suppressant activity
#21334Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives
#21335Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
#21336Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
#21337Platinum therapeutic combinations
#21338Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
#21339Synergistic combination
#21340Cancer treatment with epothilones
#21341Method of providing an antihistaminic effect in a hepatically impaired patient
#21342Caspase inhibitors as anticancer agents
#21343Inhibition of platelet aggregation
#2134439-desmethoxyrapamycin, compositions and methods of use thereof
#21345Combination of a serotonin reuptake inhibitors and agomelatine
#21346Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid
#21347Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
#21348Combination therapy for endothelial dysfunction, angina and diabetes
#21349Combinations comprising antimuscarinic agents and corticosteroids
#21350Solid peroral contraceptive preparations
#21351Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
#21352Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#21353Antibiotic and combinations of antibiotic and symptomatic relief agent formulations
#21354Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
#21355Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury
#21356Combination treatment with t-PA variant and low molecular weight heparin
#21357Irrigation solution and method for inhibition of pain and inflammation
#21358Irrigation solution and method for inhibition of pain and inflammation
#21359Formulations and methods for delivery of growth factor analogs
#21360Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors
#21361Methods for increasing cell and tissue viability
#21362Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
#21363Therapeutic agent for diabetes
#21364Formulations and methods for preventing and treating substance abuse and addiction
#21365Dragon's blood anti-viral materials and methods
#21366Dietary supplement and method of using same
#21367Formulation of a mixture of Free-B-Ring flavonoids and flavans as a therapeutic agent
#21368Antioxidant supplement composition for smokers and ex-smokers and method of producing thereof
#21369Superoxide anion decomposing agent
#21370Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
#21371Treatment of mucosal membranes
#21372Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
#21373Dual controlled release dosage form
#21374Pharmaceutical compositions of drugs and neutralized acidic polymers
#21375Synergistic salivation agents
#21376Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
#21377Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
#21378Methods and compositions for treating conditions of the eye
#21379Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
#21380Treatment of epithelial layer lesions
#21381Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging
#21382Pharmaceutical Compositions Based On Anticholinergics and PDE 5-Inhibitors
#21383Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
#21384Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
#21385Bicyclic heterocycles as HIV integrase inhibitors
#21386Combination of desoxypeganine and mecamylanine for the treatment of alcohol abuse
#21387Synergistic combination comprising roflumilast and (r,r) - formoterol
#21388Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
#21389Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
#21390Pharmaceutical combination for the treatment of spasticity and/or pain
#21391Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
#21392Sterol absorption inhibitor compounds
#21393medical composition
#21394Pharmaceutical composition comprising a factor VIIa and a factor XIII
#21395Derivatives of GLP-1 analogs
#21396Cell recovery
#21397Topical treatment compositions
#21398Pharmaceutical, therapeutic, and dietary compositions derived from Lagerstroemia speciosa L. plant
#21399Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
#21400Pharmaceutical compositions comprising an extract of
#21401Topical medicament and method of use
#21402Bioactive Agent Compositions for Repair of Cell Injuries
#21403Supplemental dietary composition for supporting muscle growth, recovery and strength
#21404Method for preventing ulceration or irritation of mucosa
#21405Roflumilast and integrin inhibitor combination and treatement method
#21406Plant based dietary supplement for improving the duration and quality of sleep
#21407Methods for treating neovascularization and intravitreal implants
#21408Combinations for the treatment of diseases involving angiogenesis
#21409Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
#21410Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
#21411Combination enzyme for cystic fibrosis
#21412Method of treating hit patients with argatroban
#21413Chaperonin 10 immunosuppression
#21414Ubiquinone composition and a container for its convenient transport and storage
#21415Treatments for virus infection
#21416Compositions and methods for treating viral infections
#21417Materials and methods for preventing and treating microbe-mediated epithelial disorders
#21418Plant based formulations for improving skin moisture, texture, and appearance
#21419Gamma-amino butyric acid composition
#21420Capsaicinoid decontamination compositions and methods of use
#21421Buccal, polar and non-polar spray containing ondansetron
#21422Methods of cardioprotection using dichloroacetate in combination with an inotrope
#21423Methods of treating epileptogenesis and epilepsy
#21424Method of treating migraines and pharmaceutical compositions
#21425Compositions and methods for treating or preventing flaviviridae infections
#21426Pharmaceutical combinations of hydrocodone and naltrexone
#21427Clinical applications of tetrahydrobiopterin, lipoic acid and their salts and methods of preparing tetrahydrobiopterin bis-lipoate
#21428Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases
#21429Method of treatment for preventing or reducing tumor growth in the liver of patient
#21430Methods for modulating tumor growth and metastasis
#21431Combinations comprising anti-epileptic drugs for the treatment of neurological disorders
#21432Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol
#21433Cystitis treatment with high dose chondroitin sulfate
#21434Compositions and methods for regulating an immune response in a subject
#21435Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
#21436NOD1 as an anti-tumor agent
#21437Method of promoting natural bypass
#21438Surfactant treatment regimen
#21439Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement
#21440Cultured cd14+ antigen presenting cells
#21441Immunotherapy for immune suppressed patients
#21442Lactobacillus specific probes
#21443Preventive or remedy for arthritis
#21444Method for treating or preventing symptoms associated with menopause
#21445Novel herbal compositions and process for preparation thereof
#21446Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
#21447Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
#21448Side effect-relieving agents and/or hypoglycemic effect enhancers for thiazolidine compounds
#21449Antimicrobial combination therapy
#21450Compositions and methods for increasing muscle mass and strength, improving athletic performance, and/or reducing body fat mass leading to weight loss
#21451Compositions and methods for the treatment of acne
#21452Formulations of peptides for periodontal and dental treatments
#21453NGNA compositions and methods of use
#21454Liposome loading with metal ions
#21455Pharmaceutical compositions containing active agents having a lactone group and transition metal ions
#21456Topical formulations comprising ceramic hydroxyapatite particles
#21457Compositions and methods of making sustained release liquid formulations
#21458Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#21459Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
#21460Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
#21461Carrier with solid fibrinogen and solid thrombin
#21462Combination therapy for controlled carbohydrate digestion
#21463Perivascular mesenchymal precursor cell induced blood vessel formation
#21464Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
#21465Method and composition for treating diabetes
#21466Method and composition for repairing heart tissue
#21467Treatment of congestive heart failure
#21468Antiprotozoal composition
#21469Use of pleiotrophin to promote neurogeneration
#21470Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
#21471Methods to mobilize progenitor/stem cells
#21472Antiseptic spermicidal composition and means for its application
#21473Immunostimulating polyphosphazene compounds
#21474Topical cosmetic composition with skin rejuvenation benefits
#21475Compositions containing amines and use thereof
#21476Compositions containing amines and use thereof
#21477Appetite suppressant mouth spray
#21478Drugs for treating cancer
#21479Instrumented thoracic model
#21480Method for preparing anti-MIF antibodies
#21481Composition and method for treating neurological disease
#21482C10 cyclopropyl ester substituted taxane compositions
#21483Combinations comprising antimuscarinic agents and beta-adrenergic agonists
#21484Compositions useful for increasing lower esophageal sphincter pressure
#21485Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
#21486Immunosuppressive effects of pteridine derivatives
#214871, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders
#21488Treating alcohol and or substance abuse by antagonizing alpha 2 adrenergic receptors with weak dopamine blocking
#21489Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
#21490Use for budesonide and formoterol
#21491Pharmaceutical combinations
#214921-Adamantyl chalcones for the treatment of proliferative disorders
#21493Tyrosine kinase inhibitors
#21494Use of lipid conjugates in the treatment of infection
#21495Use of lipid conjugates in the treatment of infection
#21496Use of lipid conjugates in the treatment of infection
#21497Use of lipid conjugates in the treatment of infection
#21498Regulation of oncogenes by microRNAs
#21499Dispenser for dispensing three or more actives
#21500Combination therapies for fungal pathogens
#21501Compositions and methods for the treatment of leukemia
#21502Preventive or therapeutic composition for viral infectious disease
#21503Peptides for diagnostic and therapeutic methods for celiac sprue
#21504Treating the effects of nicotine
#21505Combination treatment using exendins and thiazolidinediones
#21506Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
#21507Methods of treating disease with random copolymers
#21508Pharmaceutical compositions based on anticholinergics and pegsunercept
#21509Modification of feeding behaviour
#21510Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging
#21511Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
#21512Metal-containing compositions, preparations and uses
#21513Method of providing readily available cellular material derived from cord blood, and a composition thereof
#21514Methods and products for enhancing immune responses using imidazoquinoline compounds
#21515Diaminophenothiazine compositions and uses thereof
#21516Nutritional supplement preparation with piperine
#21517Cyclooxygenase-2 inhibitory withanolide compositions and method
#21518Compositions for treating diabetes or obesity
#21519Oral care compositions derived from the family
#21520Herbal preparation to relieve inflammation and smooth muscle contraction
#21521Compositions and methods for enhancing therapeutic effects
#21522NERIUM OLEANDER EXTRACT
#21523CONTROLLED RELEASE LIPOIC ACID
#21524Controlled release of S-methoprene and other active ingredients with activated carbon
#21525Topical cosmetic compositions comprising alpha arbutin
#21526Animal feed compositions capable of reducing the incidence of fescue toxicosis in mammals
#21527Delivery of bio-available compounds with anhydrous topical preparations
#21528Bile preparations for gastrointestinal disorders
#21529Treatment of T cell disorders
#21530Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
#21531Therapy-enhancing glucan
#21532Anti-IL-6 antibodies, compositions, methods and uses
#21533Methods of using death receptor agonists and EGFR inhibitors
#21534Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity
#21535Topical management of ocular and periocular conditions
#21536Wound care polymer compositions and methods for use thereof
#21537Viral vectors
#21538Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders
#21539Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#21540METHODS OF TREATING EPITHELIAL LESIONS
#21541SYSTEM AND METHOD FOR SUPPRESSING A COUGH
#21542Theraputic Skin Treatment Method
#21543Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
#21544Method for the medicinal prophylaxis of cholinesterase inhibitor intoxication, and active substances and medicaments suitable therefor
#21545Method of treating hematologic tumors and cancers
#21546Osteogenesis-promotion enhancer and method of screening the same
#21547Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
#21548Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors
#21549Methods of treating cancer using an FPT inhibitor and antineoplastic agents
#21550Combination of gh secret agogues and pde4 inhibitors for the treatment of alzheimers disease
#21551Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
#21552Method for treating depression and/or anxiety
#21553Combination chemotherapy compositions and methods
#21554PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND ETIPREDNOL
#21555Compositions of unconjugated estrogens and methods for their use
#21556Compositions of low molecular weight heparin produced with modified heparinase III
#21557Topical delivery of trace metals for skin care
#21558Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#21559Ophthalmic formulations and uses thereof
#21560Hepatitis C virus inhibitors
#21561Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
#21562PEPTIDE PHARMACEUTICAL FORMULATIONS
#21563Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
#21564Remedy for ischemia
#21565Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes
#21566Pharmaceutical composition for delayed hypersensitivity
#21567METHODS OF REDUCING LIPID PEROXIDATION AND ACHIEVING RELATED HEALTH BENEFITS BY THE ADMINISTRATION OF TOCOPHEROL AND SESAME LIGNANS
#21568Product and process for elevating lipid blood levels in livestock
#21569Methods and compounds for the treatment of obesity and obesity-related disorders
#21570Soap scent patch and treatment for muscle spasm and pain
#21571Biochemically balanced peritoneal dialysis solutions
#21572Colloidal silver composition having antimicrobial properties
#21573Sequestered antagonist formulations
#21574Anthistamine-decongestant pharmaceutical compositions
#21575Dermal medicaments application enhancer
#21576Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
#21577Methods for preparing low molecular weight heparin with modified heparinase III
#21578Composition for mitigating a pernicious thrombotic event
#21579Combat/training antioxidant micronutrient formulation and method of administration
#21580Lactic acid bacteria capable of stimulating mucosal immunity
#21581Method for expansion of stem cells
#21582Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof
#21583Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-ss
#21584CCR ligands for stem cell homing
#21585Prebiotically active plant extracts
#21586Methods for reduced renal uptake of protein conjugates
#21587Personal communication center performance display and status alert system
#21588Transgenic mice expressing human cd20
#215893′-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2′-hydroxy-[1,1′-piphenyl]-acid bis-(monoethanolamine)
#21590Serotonin and catecholamine system segment optimization technology
#21591Combined treatment with capecitabine and an epidermal growth factor receptor kinase inhibitor
#21592Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-]pyrimidines
#21593Use of a vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation
#21594Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
#21595Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents
#21596Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID
#21597Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#21598Hyaluronan as a chemo-sensitizer in the treatment of cancer
#21599Use of aurora kinase inhibitors for reducing the resistance of cancer cells
#21600Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof